Dmitry Karshtedt is quoted by Bloomberg Law about how a Federal Circuit decision could lead to changes for the generic drug industry.
"Glaxo/Teva Ruling Could Spell Trouble for Generic Drug Makers"
October 5, 2020
Dmitry Karshtedt is quoted by Bloomberg Law about how a Federal Circuit decision could lead to changes for the generic drug industry.